1. Predictive Value of Serum Inflammatory Markers on Activity of Ulcerative Colitis
   小梅 马, 2024, Advances in Clinical Medicine CrossRef
2. Natural compounds target programmed cell death (PCD) signaling mechanism to treat ulcerative colitis: a review
   Bo Chen et al, 2024, Frontiers in Pharmacology CrossRef
3. Inhibition of NLRP3 Inflammasome Activation and Pyroptosis in Macrophages by Taraxasterol Is Associated With Its Regulation on mTOR Signaling
   Fan Yang et al, 2021, Frontiers in Immunology CrossRef
4. Harnessing nature’s pharmacy: investigating natural compounds as novel therapeutics for ulcerative colitis
   You Huang et al, 2024, Frontiers in Pharmacology CrossRef
5. Syringin ameliorates dextran sulphate colitis via alteration oxidative stress, inflammation NF‐κB signalling pathway and gut microbiota
   Juhui Zhao et al, 2025, Basic & Clinical Pharmacology & Toxicology CrossRef
6. Nutraceuticals in the Treatment of Inflammatory Bowel Disease: How the Panorama has Changed in the Last Decade?
   Antonella Smeriglio et al, 2023, Current Medicinal Chemistry CrossRef
7. The relationship between aflatoxin B1 with the induction of extrinsic/intrinsic pathways of apoptosis and the protective role of taraxasterol in TM3 leydig cell line
   Cyrus Jalili et al, 2024, Ecotoxicology and Environmental Safety CrossRef
8. ADS024, a single-strain live biotherapeutic product of Bacillus velezensis alleviates dextran sulfate-mediated colitis in mice, protects human colonic epithelial cells against apoptosis, and maintains epithelial barrier function
   Sophie Irwin et al, 2024, Frontiers in Microbiology CrossRef
9. Pharmacological Action and Research Progress of Taraxasterol
   Yu Zhang et al, 2024, Current Pharmaceutical Biotechnology CrossRef
10. Treatment repurposing for inflammatory bowel disease using literature-related discovery and innovation
    Ronald Neil Kostoff et al, 2020, World Journal of Gastroenterology CrossRef
11. Dandelion root extracts and taraxasterol inhibit LPS‑induced colorectal cancer cell viability by blocking TLR4‑NFκB‑driven ACE2 and TMPRSS2 pathways
    Kerry Yang et al, 2024, Experimental and Therapeutic Medicine CrossRef
12. The phytochemical and pharmacological profile of taraxasterol
    Fengjuan Jiao et al, 2022, Frontiers in Pharmacology CrossRef